
Keywords: surveillance; hepatocellular carcinoma; prevention; cost effective strategyAFP, alpha-fetoprotein; CI, confidence interval; CLD, chronic liver disease; DCP, des-γ-carboxy-prothrombin; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C